Human Milk Oligosaccharides Market Size To Reach USD 415.6 MN In 2030 | Growing Demand For HMO In Infant Formula And Rising Application In Functional Foods Are Driving HMO Market Revenue Growth, Says Reports and Data

NEW YORK, March 2, 2022 /PRNewswire/ -- The global Human Milk Oligosaccharides (HMO) market size is expected to reach USD 415.6 Million in 2030 and register a revenue CAGR of 14.9 % over the forecast period, according to the latest report by Reports and Data. The market revenue growth is being driven owing to an increase in application scope in functional food & beverages and infant formula, rapid technological advancement, rising health awareness, and rapid development of the dairy industry.

HMOs are essential components of human milk that come in a wide range of compositions. HMOs produced by companies need to be approved by the Food and Drug Administration (FDA), as opposed to dietary supplements, which are controlled by the Generally Recognized as Safe (GRAS) Act. In the US, DuPont's CARE4U was GRAS-approved for use in infant formula and toddler meals., Two HMOs have completed a revolutionary food safety assessment in Europe owing to an increase in demand for HMOs, which resulted in a favorable evaluation conclusion and European Commission approval. HMOs have been employed in infant formula and human milk for a long time. The route to the market for new and unique HMOs as a dietary supplement is to have GRAS self-affirmed for use in food and then utilize it in the same manner as a dietary supplement. Such alerts have been issued for 2'-O-fucosyllactose, 2'-fucosyllactose, and lacto-N-neotetraose.

For More Industry Insight, Request Sample@ https://www.reportsanddata.com/download-summary-form/1303

Some Key Highlights from the Report:

• By deployment type, lacto-N-neotetraose segment accounted for largest market revenue share in 2021 as it aids in increasing growth of beneficial bifidobacteria and decreasing growth of pathogenic bacteria, which attracts food and beverage manufacturers as a result of the growing awareness about human milk oligosaccharides among customers. 
• Fucosyllactose segment revenue is expected to increase at fastest CAGR during the forecast period, as dietary supplement producers transition to Fucosyllactose, owing to its capacity to modify gut microbiota composition and behavior aiding in good digestion.
• The overall number of neutral and acidic structures based on MALDI-MS analysis of total human milk carbohydrate SEC-fractions is expected to reach 1,000 distinct structures, according to Frontiers Pediatric Immunology. Competing enzymes create oligosaccharides, which have a wide structural variety and variability that distinguishes this class of substances. The monosaccharides glucose (Glc), galactose (Gal), N-acetylglucosamine (GlcNAc), fucose (Fuc), and sialic acid (N-acetylneuraminic acid) make up HMOs (Neu5Ac). HMOs, on the other hand, do not necessarily have all five monosaccharides in their composition.
• By application, infant formula segment accounted for largest market revenue share in 2021 because of HMOs' therapeutic properties, such as infection prevention, prebiotic effects, memory improvement, brain development, and gut health maintenance.
• Human milk oligosaccharides market in Asia Pacific is expected to grow at fastest CAGR over the forecast period owing to factors such as increasing population, fatality rate, expendable income, and consumer awareness about health and hygiene. Concerns about gastrointestinal diseases, high blood pressure, diabetes, and rickets, among other chronic illnesses, have boosted demand for functional foods and drinks, which is expected to drive demand for human milk oligosaccharides in the region. Furthermore, markets for dietary supplements and baby food are rapidly increasing in India and China, which is projected to boost product demand during the forecast period.
• Companies profiled in global HMO market report include Inbiose NV, ELICITYL SA, Chr. Hansen Holding A/S, Glycom A/S, Abbott, ZuChem Inc., Glycosyn, Inc., Dextra Laboratories, DuPont (Nutrition & Biosciences), and FrieslandCampina.

Request For Custom Research @ https://www.reportsanddata.com/request-customization-form/1303

For the purpose of this report, Reports and Data has segmented human milk oligosaccharides market based on component, technology, type, application, and region:

• Product Outlook (Revenue, USD Million; 2019–2030)
• Fucosyllactose
• Sialyllactose
• Lacto-N-Tetraose
• Lacto-N-Neotetraose
• Technology Outlook (Revenue, USD Million; 2019–2030)
• HMO Production Technology
• Chemo-enzymatic synthesis
• Whole-cell biocatalysis
• Sialyltransferases
• Glycosyltransferases
• Fucosyltransferases
• Separation & Analysis

Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/1303

• Type Outlook (Revenue, USD Million; 2019–2030)

• Acidic
• Neutral

• Application Outlook (Revenue, USD Million; 2019–2030)
• Functional Food & Beverages
• Infant Formula
• Food Supplements
• Others
• Regional Outlook (Revenue, USD Billion; 2019–2030)
• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Sweden
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Rest of MEA

Browse for More Details:

Nonfat Milk Powder Market By Applications (Confectionery & Bakery, Nutritional Food), By Form Factor (Ordinary, Agglomerated), By Processing Treatment (Low-heat, High-heat), By Distribution Channel (Online, Hypermarket, Retail Stores) And Segment Forecasts, 2016-2027

Soy Milk Market, Share & Trends Analysis by Form (Sweetened, Unsweetened), by Distribution Channel (Online, Hypermarkets/Supermarkets, Retail, Others), by Application (Cheese, Desserts, Snacks, Beverages, Others), by Region, Competitive Strategies and Segment Forecasts, 2016- 2026

Skimmed Milk Market Size, Share, Demand By Application (Confectionery, Bakery, Prepared Mix, Dairy, Others), By Distribution Channel (Convenience Store, Online Store, Supermarket, Hypermarket, Wholesalers), By Region, Competitive Strategies and Segment Forecasts for 2016 - 2026

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-human-milk-oligosaccharides-hmo-market

Logo: https://mma.prnewswire.com/media/1579615/Reports_and_Data_Logo.jpg